Efficacy News and Research

RSS
PharmAthene awarded total of $78.4M in additional funding to develop SparVax vaccine

PharmAthene awarded total of $78.4M in additional funding to develop SparVax vaccine

Sentry BioPharma Services to warehouse and distribute influenza vaccines for CDC

Sentry BioPharma Services to warehouse and distribute influenza vaccines for CDC

New treatments for heart disease

New treatments for heart disease

BSD2000 deep hyperthermia combined with chemotherapy improves quality of life in NSCLC patients

BSD2000 deep hyperthermia combined with chemotherapy improves quality of life in NSCLC patients

ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI

ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI

Sopris and Tufts University to publish reading intervention program for students

Sopris and Tufts University to publish reading intervention program for students

Prednisolone associated with recurrence of CAP after its withdrawal

Prednisolone associated with recurrence of CAP after its withdrawal

Findings suggest bitter melon extract may help in preventing breast cancer

Findings suggest bitter melon extract may help in preventing breast cancer

NASDAQ halts trading of Salix Pharmaceuticals stock, FDA Committee to discuss XIFAXAN NDA

NASDAQ halts trading of Salix Pharmaceuticals stock, FDA Committee to discuss XIFAXAN NDA

Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients

Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients

FDA issues approval for Gileads's Cayston for respiratory symptoms in cystic fibrosis

FDA issues approval for Gileads's Cayston for respiratory symptoms in cystic fibrosis

Obecure granted patent covering betahistine with olanzapine for mitigating antipsychotic drug associated weight gain

Obecure granted patent covering betahistine with olanzapine for mitigating antipsychotic drug associated weight gain

Newborn Possibilities program for babies at-risk for neurological injury

Newborn Possibilities program for babies at-risk for neurological injury

Viamet Pharmaceuticals, Novartis Option Fund partner to develop novel inhibitors against key metalloenzyme target

Viamet Pharmaceuticals, Novartis Option Fund partner to develop novel inhibitors against key metalloenzyme target

Merrimack Pharmaceuticals commences dosing in MM-121/Tarceva combination Phase 1/2 study for NSCLC

Merrimack Pharmaceuticals commences dosing in MM-121/Tarceva combination Phase 1/2 study for NSCLC

Amylin Pharmaceuticals and Takeda Pharmaceutical to advance pramlintide/metreleptin combination therapy development

Amylin Pharmaceuticals and Takeda Pharmaceutical to advance pramlintide/metreleptin combination therapy development

AAN guideline evaluates drugs’ safety and efficacy for treatment of muscle cramps

AAN guideline evaluates drugs’ safety and efficacy for treatment of muscle cramps

BioSante Pharmaceuticals' ongoing LibiGel Phase III clinical development program: Additional positive data

BioSante Pharmaceuticals' ongoing LibiGel Phase III clinical development program: Additional positive data

Alnylam Pharmaceuticals initiates ALN-RSV01 Phase IIb trial in adult lung transplant patients for RSV infection

Alnylam Pharmaceuticals initiates ALN-RSV01 Phase IIb trial in adult lung transplant patients for RSV infection

Highest assault rates associated with carry-out sites selling alcohol for off-premise consumption

Highest assault rates associated with carry-out sites selling alcohol for off-premise consumption

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.